U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C9H11NO2
Molecular Weight 165.1891
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PHENYLALANINE

SMILES

N[C@@H](CC1=CC=CC=C1)C(O)=O

InChI

InChIKey=COLNVLDHVKWLRT-QMMMGPOBSA-N
InChI=1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)/t8-/m0/s1

HIDE SMILES / InChI

Molecular Formula C9H11NO2
Molecular Weight 165.1891
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Phenylalanine is a biologically essential amino acid that acts as a precursor to tyrosine and the catecholamines (epinephrine, norepinephrine, dopamine, and tyramine), and is a constituent of many central nervous system neuropeptides. Normal dietary levels of phenylalanine are approximately 1-2 grams daily. Phenylalanine appears in two forms which are identical mirror images of each other: L-phenylalanine, a nutritional supplement, and D-phenylalanine, an effective painkiller and antidepressant due to its ability to inhibit the breakdown of enkephalins, the brain’s natural pain killers.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
FREAMINE III 10%

Approved Use

Parenteral nutrition with 8.5% FreAmine® III (Amino Acid Injection) with Electrolytes is indicated to prevent nitrogen loss or treat negative nitrogen balance in adults and pediatric patients, where (1) the alimentary tract, by the oral, gastrostomy, or jejunostomy route, cannot or should not be used, or adequate protein intake is not feasible by these routes; (2) gastrointestinal absorption of protein is impaired; or (3) protein requirements are substantially increased as with extensive burns. Dosage, route of administration, and concomitant infusion of non-protein calories are dependent on various factors, such as nutritional metabolic status of the patient, anticipated duration of parenteral nutritional support, and vein tolerance

Launch Date

1971
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
1389 μM
20 mg/kg single, intravenous
dose: 20 mg/kg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
PHENYLALANINE plasma
Rattus norvegicus
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
35.7 μM × h
20 mg/kg single, intravenous
dose: 20 mg/kg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
PHENYLALANINE plasma
Rattus norvegicus
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
3 min
20 mg/kg single, intravenous
dose: 20 mg/kg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
PHENYLALANINE plasma
Rattus norvegicus
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
Doses

Doses

DosePopulationAdverse events​
1.5 g single, oral
Dose: 1.5 g
Route: oral
Route: single
Dose: 1.5 g
Sources:
healthy, 36 years
Health Status: healthy
Age Group: 36 years
Sex: M
Sources:
8.2 g single, intravenous (total)
Highest studied dose
Dose: 8.2 g
Route: intravenous
Route: single
Dose: 8.2 g
Sources:
healthy, adult
n = 1
Health Status: healthy
Age Group: adult
Sex: M
Population Size: 1
Sources:
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Ten novel mutations in the phenylalanine hydroxylase gene (PAH) observed in Brazilian patients with phenylketonuria.
2001
Self-association of the H3 region of syntaxin 1A. Implications for intermediates in SNARE complex assembly.
2001 Apr 20
Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter.
2001 Feb
Auto-inhibition of Ca(2+)/calmodulin-dependent protein kinase II by its ATP-binding domain.
2001 Feb
In vivo protein synthetic rates of atrial, ventricular, and pulmonary tissue proteins in aortic constriction, goldblatt, and bromoethylamine models of hypertension.
2001 Feb
Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity.
2001 Feb 19
Kynurenine aminotransferase I activity in human placenta.
2001 Feb-Mar
The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation.
2001 Jan
Physical stability of the blue pigments formed from geniposide of gardenia fruits: effects of pH, temperature, and light.
2001 Jan
New analogues of bradykinin containing a conformationally restricted dipeptide fragment in their molecules.
2001 Jan
The unique tryptophan residue of the vitamin D receptor is critical for ligand binding and transcriptional activation.
2001 Jan
The protein-retaining effects of growth hormone during fasting involve inhibition of muscle-protein breakdown.
2001 Jan
Characterization of 3-[(123)I]iodo-L-alpha-methyl tyrosine transport in astrocytes of neonatal rats.
2001 Jan
A study of peptide--peptide interaction by matrix-assisted laser desorption/ionization.
2001 Jan
An in vivo study of ovine placental transport of essential amino acids.
2001 Jan
Amino acid phosphoramidate monoesters of 3'-azido-3'-deoxythymidine: relationship between antiviral potency and intracellular metabolism.
2001 Jan 18
A single arginyl residue in plastocyanin and in cytochrome c(6) from the cyanobacterium Anabaena sp. PCC 7119 is required for efficient reduction of photosystem I.
2001 Jan 5
Acute effects of peritoneal dialysis with dialysates containing dextrose or dextrose and amino acids on muscle protein turnover in patients with chronic renal failure.
2001 Mar
Selected Contribution: IGF-I antibody prevents increases in protein synthesis in epitrochlearis muscles from refed, diabetic rats.
2001 Mar
A possible role for metalloproteinases in renal cyst development.
2001 Mar
Patents

Sample Use Guides

L-Phenylalanine Capsules (400 mg/cap): one to two capsules per day on an empty stomach. L-Phenylalanine Powder: 480 mg one to two times per day on an empty stomach. DL-Phenylalanine Capsules (500 mg/cap): one capsule daily on an empty stomach. DL-Phenylalanine Powder: 1/8 level teaspoon two to three times daily on an empty stomach.
Route of Administration: Oral
In cultured hippocampal neurons from newborn rats L-phenylalanine specifically and reversibly attenuated NMDA-activated currents in a concentration-dependent manner (IC50=1.71 mM)
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:06:13 GMT 2023
Edited
by admin
on Fri Dec 15 15:06:13 GMT 2023
Record UNII
47E5O17Y3R
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PHENYLALANINE
EP   HSDB   II   INCI   INN   MART.   MI   USAN   USP   VANDF   WHO-DD  
INCI   USAN   INN  
Official Name English
L-PHENYLALANINE [USP-RS]
Common Name English
LEUCINE IMPURITY C [EP IMPURITY]
Common Name English
NSC-79477
Code English
TYROSINE IMPURITY A [EP IMPURITY]
Common Name English
FEMA NO. 3585
Code English
NATEGLINIDE IMPURITY D [EP IMPURITY]
Common Name English
Phenylalanine [WHO-DD]
Common Name English
3-PHENYL-L-ALANINE
Systematic Name English
PHENYLALANINE [VANDF]
Common Name English
PHENYLALANINE [INCI]
Common Name English
phenylalanine [INN]
Common Name English
PHENYLALANINE [MI]
Common Name English
L-PHENYLALANINE
FCC   FHFI   USP-RS  
Systematic Name English
L-.ALPHA.-AMINO-.BETA.-PHENYLPROPIONIC ACID
Common Name English
PHENYLALANINE [HSDB]
Common Name English
LYSINE HYDROCHLORIDE IMPURITY B [EP IMPURITY]
Common Name English
PHENYLALANINE [MART.]
Common Name English
L-PHENYLALANINE [FHFI]
Common Name English
LAEVO-PHENYL ALANINE
Common Name English
(2S)-2-AMINO-3-PHENYLPROPANOIC ACID
Systematic Name English
PHENYLALANINE [USAN]
Common Name English
L-PHENYLALANINE [JAN]
Common Name English
PHENYLALANINE [EP MONOGRAPH]
Common Name English
PHENYLALANINE [II]
Common Name English
PHENYLALANINE [USP MONOGRAPH]
Common Name English
L-PHENYLALANINE [FCC]
Common Name English
Classification Tree Code System Code
LOINC 53396-8
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 53151-7
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 13893-3
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 53398-4
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 29573-3
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 74481-3
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
CFR 21 CFR 201.21
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 53157-4
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 27362-3
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 47981-6
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 32263-6
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 55970-8
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 47724-0
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 26981-1
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 14875-9
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
JECFA EVALUATION L-PHENYLALANINE
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 47721-6
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 30055-8
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 25970-5
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 44349-9
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 53156-6
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 12803-3
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 26967-0
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 22646-4
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 2764-9
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 20653-2
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 41170-2
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 22683-7
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 49484-9
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
DSLD 1580 (Number of products:829)
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 2763-1
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 2766-4
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 32265-1
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 53394-3
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
DSLD 169 (Number of products:17)
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 47722-4
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 38495-8
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 2762-3
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 25495-3
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 57995-3
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 47725-7
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 44348-1
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 13409-8
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 21057-5
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
NCI_THESAURUS C68442
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 53153-3
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 21056-7
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 75268-3
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 35572-7
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 47723-2
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 29571-7
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 55969-0
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 25969-7
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
CFR 21 CFR 172.320
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 22737-1
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
CFR 21 CFR 201.66
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 32264-4
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 53392-7
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 18475-4
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 2768-0
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 53393-5
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 2767-2
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 29572-5
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
LOINC 2765-6
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
Code System Code Type Description
HSDB
1825
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
PRIMARY
DRUG CENTRAL
2144
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
PRIMARY
ECHA (EC/EINECS)
200-568-1
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
PRIMARY
NCI_THESAURUS
C29601
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
PRIMARY
JECFA MONOGRAPH
1418
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
PRIMARY
MESH
D010649
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
PRIMARY
PUBCHEM
6140
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
PRIMARY
INN
6168
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
PRIMARY
CHEBI
58095
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
PRIMARY
SMS_ID
100000092416
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
PRIMARY
FDA UNII
47E5O17Y3R
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
PRIMARY
ChEMBL
CHEMBL301523
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
PRIMARY
CAS
63-91-2
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
PRIMARY
CHEBI
29997
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
PRIMARY
DRUG BANK
DB00120
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
PRIMARY
RXCUI
8156
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
PRIMARY RxNorm
EVMPD
SUB32327
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
PRIMARY
EVMPD
SUB09786MIG
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
PRIMARY
NSC
79477
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
PRIMARY
WIKIPEDIA
PHENYLALANINE
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
PRIMARY
RS_ITEM_NUM
1530503
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
PRIMARY
CHEBI
17295
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
PRIMARY
DAILYMED
47E5O17Y3R
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
PRIMARY
MERCK INDEX
m8652
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
PRIMARY Merck Index
CHEBI
28044
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
PRIMARY
EPA CompTox
DTXSID4040763
Created by admin on Fri Dec 15 15:06:13 GMT 2023 , Edited by admin on Fri Dec 15 15:06:13 GMT 2023
PRIMARY
Related Record Type Details
DEGRADENT -> PARENT
Precursor is Phenylalanine
SALT/SOLVATE -> PARENT
RECOMBINANT ORGANISM->SUBSTRATE
ENZYME->SUBSTRATE
METABOLIC ENZYME -> SUBSTRATE
SALT/SOLVATE -> PARENT
LABELED -> NON-LABELED
INHIBITOR -> TARGET
INHIBITOR -> TARGET
DERIVATIVE -> PARENT
Related Record Type Details
METABOLITE -> PARENT
PARENT -> METABOLITE
METABOLITE -> PARENT
Related Record Type Details
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (TLC)
EP
PARENT -> IMPURITY
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
PARENT -> IMPURITY
EP
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (TLC)
EP
PARENT -> IMPURITY
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Related Record Type Details
ACTIVE MOIETY